The plasma membrane is the final barrier that enveloped viruses must cross during their
egress from the infected cell. Here, we review recent insights into the cell biology of retroviral …

Since the first reports of a novel severe acute respiratory syndrome (SARS)-like coronavirus
in December 2019 in Wuhan, China, there has been intense interest in understanding how …

Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…

There is a clear requirement for an accurate SARS-CoV-2 antibody test, both as a complement
to existing diagnostic capabilities and for determining community seroprevalence. We …

Human cells possess an antiviral activity that inhibits the release of retrovirus particles, and
other enveloped virus particles, and is antagonized by the HIV-1 accessory protein, Vpu. This …

The zinc finger antiviral protein (ZAP) restricts the replication of a broad range of RNA and
DNA viruses. ZAP directly binds viral RNA, targeting it for degradation and inhibiting its …

The expression of many putative antiviral genes is upregulated when cells encounter type I
interferon (IFN), but the actual mechanisms by which many IFN-induced gene products …

Type 1 interferon (IFN) inhibits the release of HIV-1 virus particles via poorly defined
mechanisms. Here, we show that IFNα induces retention of viral particles on the surface of …

Tetherin/BST-2/CD317 is a recently identified antiviral protein that blocks the release of nascent
retrovirus, and other virus, particles from infected cells. An HIV-1 accessory protein, Vpu, …

Tetherin (CD317/BST-2), an interferon-induced membrane protein, restricts the release of
nascent retroviral particles from infected cell surfaces. While human immunodeficiency virus …